Northrop Grumman Corp. Stock Advances 4.6%, Outperforms Peers
Dow Jones2026/10/20 20:34This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Northrop Grumman Corp. rose 4.6% to $534.00 on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.3% to 7,712.57 and the Dow Jones Industrial Average rising 1.0% to 52,495.88.
Northrop Grumman Corp. closed 31.0% below its 52-week high of $774.00, which the company achieved on March 3rd.
The stock outperformed some of its peers, as RTX Corp. rose 0.6% to $193.34, Boeing Co. fell 0.5% to $190.47, and Lockheed Martin Corp. rose 0.09% to $548.71.
Trading volume totaled 2.1 million, compared to the 50-day average of 858,281.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
October 20, 2026 16:34 ET (20:34 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
CoreWeave (CRWV.US) revenue doubles but faces $5.2 billions in debt pressure
CoreWeave's stock price fell by more than one-third in October. Although its Q2 revenue increased by 112% year-over-year to 2.5 billion USD, a 15% yield on unsecured bonds and an 11% CDS spread have sparked deep market concerns about the sustainability of its debt.
House of Doge (HODO.US) executives resign and terminate exclusive Dogecoin authorization
The former CEO and CFO of House of Doge have resigned, with executives from McQueen Labs taking over. The company has terminated its exclusive trademark authorization for Dogecoin, switching to a non-exclusive model that requires revenue sharing. Meanwhile, asset swaps and acquisitions are being advanced.
Vietnam VN Index closed down 0.6%
Windward Bio (WWB.US) plans to list in the US and aims to raise up to 100 million dollars, with multiple drugs licensed to Chinese pharmaceutical companies.
Windward Bio Group filed for an initial public offering (IPO) with the U.S. Securities and Exchange Commission (SEC) last Friday, aiming to raise up to 100 million dollars.
Crypto prices
More
